Last updated on December 2018

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Brief description of study

The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, is effective for the treatment of advanced pancreatic cancer.

Clinical Study Identifier: NCT03336216

Find a site near you

Start Over

Local Institution

Mannheim, Germany
  Connect »